Trung Nguyen
Family Medicine · Plano, TXNPI 1831401132
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,147, 3.4 times the $624 reported in 2019.
Across 79 payments — averaging $51.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$770
- Dexcom, Inc.$636
- AbbVie$514
- Lilly USA, LLC$433
- Amgen$279
- Novo Nordisk$267
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,048100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $770 |
| Dexcom, Inc. | 10 | $636 |
| AbbVie(2 entities) | 6 | $514 |
| Lilly USA, LLC | 9 | $433 |
| Amgen | 3 | $279 |
| Novo Nordisk | 9 | $267 |
| Idorsia Pharmaceuticals US Inc | 3 | $167 |
| AstraZeneca | 4 | $160 |
| Astellas Pharma US Inc | 3 | $158 |
| Abbott | 3 | $157 |
| GSK | 2 | $136 |
| Eisai Inc. | 1 | $128 |
| Pfizer | 2 | $48 |
| Boehringer Ingelheim | 2 | $41 |
| Exact Sciences | 1 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Althera Pharmaceuticals LLC | 1 | $21 |
| Alk-abello, Inc | 1 | $21 |
| Antares Pharma, Inc. | 1 | $19 |
| Philips North America LLC | 1 | $16 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,048 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 11 | $679 |
| Gabapentin | 11 | $465 |
| Levothyroxine Sodium | 24 | $351 |
| Metformin Hcl | 22 | $290 |
| Ipratropium Bromide | 14 | $290 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 13 | $281 |
| Atorvastatin Calcium | 19 | $238 |
| Lisinopril | 13 | $204 |
| Tamsulosin Hcl | 14 | $184 |
| Finasteride | 14 | $135 |
| Doxycycline Hyclate | 13 | $80 |
| Amlodipine Besylate | 14 | $60 |
| Naproxen | 21 | $53 |
| Prednisone | 53 | $43 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Plano
- Mahdi AwwadPlano$34K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.